Cargando…
BFL1 modulates apoptosis at the membrane level through a bifunctional and multimodal mechanism showing key differences with BCLXL
BFL1 is a relatively understudied member of the BCL2 protein family which has been implicated in the pathogenesis and chemoresistance of a variety of human cancers, including hematological malignancies and solid tumours. BFL1 is generally considered to have an antiapoptotic function, although its pr...
Autores principales: | Flores-Romero, Hector, Landeta, Olatz, Ugarte-Uribe, Begoña, Cosentino, Katia, García-Porras, Miguel, García-Sáez, Ana J., Basañez, Gorka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748131/ https://www.ncbi.nlm.nih.gov/pubmed/30560933 http://dx.doi.org/10.1038/s41418-018-0258-5 |
Ejemplares similares
-
Membrane insertion of the BAX core, but not latch domain, drives apoptotic pore formation
por: Flores-Romero, Hector, et al.
Publicado: (2017) -
BCLXL PROTAC degrader DT2216 targets secondary plasma cell leukemia addicted to BCLXL for survival
por: Champion, Ophélie, et al.
Publicado: (2023) -
Computational design of BclxL inhibitors that target transmembrane domain interactions
por: Duart, Gerard, et al.
Publicado: (2023) -
A1/Bfl-1 in leukocyte development and cell death
por: Ottina, Eleonora, et al.
Publicado: (2012) -
hBfl-1/hNOXA Interaction Studies Provide New Insights on the Role of Bfl-1 in Cancer Cell Resistance and for the Design of Novel Anticancer Agents
por: Barile, Elisa, et al.
Publicado: (2016)